What is the exit plan (acquisition, IPO, merger, etc.) in which investors will be able to see a ROI?

Hello, thank you for the question! We’re building Careverse™ to become something people rely on every day to access care — at real scale. As we grow, the most natural path is a public offering (IPO). When we reach that level, it gives investors a clear opportunity for liquidity and long-term value. Along the way, there may also be interest from large healthcare or technology companies looking to partner with or acquire a platform like Careverse™. We’ll stay open to those opportunities if they...

good stuff. I invested in a chain of medical clinics, surgery centers and other industries that this could be a good fit for if the companies don't already have it. would have to chat with founders 1. what I am wondering is what makes you different than others, you aren't the ...

John, Thank you — really appreciate the note and your background. This is exactly the kind of use case we’re building for. 1. What makes Careverse™ different You’re right — there are other players. Most of them solve parts of the problem (directories, booking, telehealth, point solutions). Careverse is built to orchestrate care end-to-end — from the moment someone asks for help to actually getting care completed. In simple terms: Not just find a provider → match, verify, and execute care Not ...

Very interesting project. 1- is there a patent or intellectual property protection accepted? 2- how you decide this is a 25t dollar industry? 3- in simple, what the company actually do?

Hello Etai,Thanks for the note :1) IP / ProtectionWe are actively working with counsel on trademark and intellectual property protection for Careverse, including brand and core platform elements.At the same time, our defensibility is designed to go beyond just filings:Proprietary AI + care orchestration layerProvider + user network effectsData and workflow intelligenceEcosystem integrationsSimilar to companies like Uber or OpenAI, long-term protection comes from a combination of IP, scale, an...

Thank you for your thoughtful answers. In related: 1)About the patent/intellectual property i asked; can someone copy you right now? 3) so it's kind of verified chat gpt or Google of health? (I focus mainly on this part, and not on the global meeting online part because of reg...

Thank you Etai — really thoughtful follow-up questions.1) Can someone copy this today?At a surface level, parts of any early-stage product can be replicated — that’s true across most tech.Where we’re focused is building proprietary components that are uniquely ours, including:Care routing and triage logicWorkflow orchestration across providersData models that improve recommendations over timeThese are areas we are intentionally developing as core IP, alongside ongoing trademark and intellectu...

thanks for response Alex! I was able to get onto the link you provided. you mentioned that monetization comes from bookings/transactions. I don't see nothing about that. how much do you make from that? another thing you mentioned as far as monetization was advertising(care and...

Thank you for the thoughtful questions — really appreciate you taking the time to dig deeper.One thing I should clarify from my earlier message: our long-term vision is actually to make the core Careverse experience free for both users and providers. We believe lowering friction creates a much larger ecosystem and stronger long-term network effects.For users:free AI care navigationprovider/service discoverycoordination assistancecare record retention/historyprovider validation/transparency to...

Invest in Careverse AI

Making Care Ridiculously Easy

EARLY BIRD TERMS: $49,828 LEFT

$207,172

raised from 27+ investors

INVEST

min $100

INVESTMENT TERMS

Convertible Note

$50M $45M valuation cap 8% interest

Early Bird Bonus: The first $123K of investments will be in a convertible note with a $45M valuation cap

careverse.us

Washington, DC

Technology Marketplace B2B Healthcare SaaS

Ask a Question

Careverse AI

Quick facts

Team profiles

Featured investor profiles

$207,172

Ask